Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

Learn how we empower organizations to operate confidently, knowing their workloads run on a platform designed to meet stringent expectations.

Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...

Artificial intelligence could soon help patients make sense of complex medical scan results, making them far easier to ...

New AI tools from Anthropic sparked a broad sell-off in software and data stocks. Executives say fears are overblown, but analysts warn of margin and pricing pressure. Investors are reassessing which ...

Anthropic just launched a new AI tool that could replace dozens of software tools. And Wall Street is panicked. Claude Cowork is meant to be like an AI colleague, with the ability to read files, ...

Amanda Smith is a freelance journalist and writer. She reports on culture, society, human interest and technology. Her stories hold a mirror to society, reflecting both its malaise and its beauty.

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

Nine-Point-Seven Percent CAGR Reflects Fundamental Industry Shift Toward Advanced LC-MS/MS and High-Resolution Platforms Across R&D, Manufacturing, and Outsourced Bioanalytical TestingDelray Beach, FL ...

Purdue’s strategic initiatives, which include leveraging the university’s extensive technological and computational environment and tackling complex challenges at the intersection of human, animal and ...

In the ever-changing and fiercely competitive business landscape, conducting thorough company analysis is crucial for investors and industry experts. In this article, we will undertake a comprehensive ...